The demand for high-quality Critical Care medicines is rapidly increasing across India. Among the most essential NICU products, Caffeine Citrate Injection has become a highly preferred solution for treating apnea in premature infants.
Medizia Biotech offers Caffeine Citrate Injection 1ml, 2ml, 3ml with ready stock availability and attractive pharma franchise opportunities across India.
If you are looking for a reliable pharmaceutical company WHO-GMP compliant production units for neonatal and critical care injection franchise business, Medizia Biotech provides quality products, marketing support, and nationwide distribution opportunities.
Caffeine Citrate Injection is a neonatal critical care medicine primarily used for the treatment of Apnea of Prematurity (AOP) in premature newborn babies.
It helps stimulate breathing by activating the central nervous system and improving respiratory function in infants admitted to NICUs.
At Medizia Biotech, we provide:
The increasing number of premature births and growing neonatal healthcare awareness have significantly boosted the demand for caffeine citrate injections in India.
The injection helps reduce apnea episodes and improves breathing efficiency in premature infants.
Trusted by pediatricians and neonatal specialists across hospitals and critical care centers.
Provides quick respiratory stimulation and supports oxygen regulation.
Clinically accepted and commonly used in neonatal intensive care treatments.
Medizia Biotech offers Pharma Franchise for Caffeine Citrate Injection with ready stock supply across India.
Medizia Biotech is committed to delivering advanced pharmaceutical formulations with consistent quality and customer satisfaction.
Caffeine Citrate Injection is commonly used in: